September 21, 2017 7:47 AM ET

Pharmaceuticals

Company Overview of Laboratoires Mayoly Spindler S.A.S.

Key Executives for Laboratoires Mayoly Spindler S.A.S.

NameBoard RelationshipsTitleAge
Jean-Nicolas Vernin 5 RelationshipsChief Executive Officer, President, Member of Executive Committee and Member of Supervisory Board--
- Mayoly No RelationshipsFounder--
- Spindler No RelationshipsFounder--
Stéphane Thiroloix 5 RelationshipsManaging Director, Member of Executive Committee and Member of Supervisory Board--

Laboratoires Mayoly Spindler S.A.S. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Olivier Vernin 5 RelationshipsLaboratoires Mayoly Spindler S.A.S.--
Jean-Nicolas Vernin 5 RelationshipsLaboratoires Mayoly Spindler S.A.S.--
Stéphane Thiroloix 5 RelationshipsLaboratoires Mayoly Spindler S.A.S.--
Claude Brunet 5 RelationshipsLaboratoires Mayoly Spindler S.A.S.60
Olivier Jacquesson 14 RelationshipsLaboratoires Mayoly Spindler S.A.S.67
View All Board Members

Laboratoires Mayoly Spindler S.A.S. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Supervisory Board Olivier Vernin5 Relationships6 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
406.6K
Bonus
417.3K
Total Short Term Compensation
569.1K
Total Value of Options
8.1M
Compensation as of Fiscal Year
Laboratoires Mayoly Spindler S.A.S. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Huaren Pharmaceutical Announces Executive Changes; and Approves Cash Dividend of 2016
September 19, 2017 3:32 PM ET
FluGen Inc. Names Robert Belshe as Chairman of its Clinical Advisory Board
September 19, 2017 2:00 PM ET
Juniper Pharmaceuticals, Inc. Approves Reduction of Workforce by Approximately 8%; Announces Resignation of Bridget Martell, M.D. as Chief Medical Officer
September 19, 2017 12:34 PM ET
PLx Pharma Inc. Announces Executive Appointments
September 19, 2017 10:50 AM ET
Aerie Pharmaceuticals, Inc. Announces Executive Changes
September 19, 2017 10:30 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Laboratoires Mayoly Spindler S.A.S., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.